Susan E. Bates

51.5k total citations · 8 hit papers
453 papers, 38.5k citations indexed

About

Susan E. Bates is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Susan E. Bates has authored 453 papers receiving a total of 38.5k indexed citations (citations by other indexed papers that have themselves been cited), including 293 papers in Oncology, 205 papers in Molecular Biology and 62 papers in Cancer Research. Recurrent topics in Susan E. Bates's work include Drug Transport and Resistance Mechanisms (153 papers), Histone Deacetylase Inhibitors Research (70 papers) and Cancer therapeutics and mechanisms (54 papers). Susan E. Bates is often cited by papers focused on Drug Transport and Resistance Mechanisms (153 papers), Histone Deacetylase Inhibitors Research (70 papers) and Cancer therapeutics and mechanisms (54 papers). Susan E. Bates collaborates with scholars based in United States, United Kingdom and Israel. Susan E. Bates's co-authors include Tito Fojo, Michael M. Gottesman, Robert W. Robey, Michael Dean, Antonio Tito Fojo, Thomas Litman, Richard Piekarz, Orsolya Polgár, Wilfred D. Stein and Zhirong Zhan and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Susan E. Bates

434 papers receiving 37.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Multidrug resistance in cancer: role of ATP–dependent transporters

2002 4.5k citations Tito Fojo, Susan E. Bates et al. profile →
Tumour stem cells and drug resistance

2005 3.0k citations Tito Fojo, Susan E. Bates et al. profile →
Revisiting the role of ABC transporters in multidrug-resistant cancer

2018 1.4k citations Robert W. Robey, Antonio Tito Fojo et al. profile →
Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

1999 674 citations Thomas Litman, Zhirong Zhan et al. profile →
The Role of ABC Transporters in Clinical Practice

2003 648 citations Tito Fojo, Susan E. Bates et al. profile →
From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance

2001 574 citations Thomas Litman, Wilfred D. Stein et al. profile →
Phase II Multi-Institutional Trial of the Histone Deacetylase Inhibitor Romidepsin As Monotherapy for Patients With Cutaneous T-Cell Lymphoma

2009 561 citations Richard Piekarz, Robin Frye et al. profile →
Epigenetic Therapies for Cancer

2020 320 citations Susan E. Bates profile →

Peers

Countries citing papers authored by Susan E. Bates

Since Specialization

Citations

This map shows the geographic impact of Susan E. Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Bates more than expected).

Fields of papers citing papers by Susan E. Bates

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan E. Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Bates. The network helps show where Susan E. Bates may publish in the future.

Co-authorship network of co-authors of Susan E. Bates

This figure shows the co-authorship network connecting the top 25 collaborators of Susan E. Bates. A scholar is included among the top collaborators of Susan E. Bates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan E. Bates. Susan E. Bates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Overcoming Resistance to DNA-Targeted Agents by Epigenetic Activation of Schlafen 11 ( SLFN11) Expression with Class I Histone Deacetylase Inhibitors 2018 ·Clinical Cancer Research ·Sai-Wen Tang, Anish Thomas, Junko Murai, Jane B. Trepel, Susan E. Bates, Vinodh N. Rajapakse, Yves Pommier	65
2	Effects of Anticancer Drugs on Chromosome Instability and New Clinical Implications for Tumor-Suppressing Therapies 2016 ·Cancer Research ·Hee-Sheung Lee, Nathan Lee, Natalay Kouprina, Junghyun Kim, (unknown), Susan E. Bates, Jane B. Trepel, Yves Pommier, Dan L. Sackett, Vladimir Larionov	57
3	Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma 2015 ·Clinical Cancer Research ·Salvia Jain, (unknown), Kelly Zullo, Luigi Scotto, Carmine F. Palermo, Stephen A. Sastra, Kenneth P. Olive, Serge Cremers, Tiffany Thomas, (unknown), Yuan Zhang, Govind Bhagat, Jennifer E. Amengual, Changchun Deng, Charles Karan, Ronald Realubit, Susan E. Bates, Owen A. O’Connor	49
4	A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent 2014 ·Clinical Cancer Research ·Leonard J. Appleman, Sanjeeve Balasubramaniam, Robert A. Parise, (unknown), Christophe E. Redon, Asako Nakamura, William M. Bonner, James R. Wright, Richard Piekarz, David Köhler, Yixing Jiang, Chandra P. Belani, Julie L. Eiseman, Edward Chu, Jan H. Beumer, Susan E. Bates	5
5	Phase I Trial of a New Schedule of Romidepsin in Patients with Advanced Cancers 2013 ·Clinical Cancer Research ·Laleh Amiri‐Kordestani, Victoria Luchenko, Cody J. Peer, Kambiz Ghafourian, James C. Reynolds, (unknown), Robin Frye, (unknown), David Venzon, John J. Wright, Monica C. Skarulis, William D. Figg, Tito Fojo, Susan E. Bates, Richard Piekarz	57
6	Electrocardiographic Studies of Romidepsin Demonstrate Its Safety and Identify a Potential Role for KATP Channel 2013 ·Clinical Cancer Research ·Anne M. Noonan, (unknown), David J. Liewehr, Tristan M. Sissung, David Venzon, Thomas P. Flagg, Mark C. Haigney, Seth M. Steinberg, William D. Figg, Richard Piekarz, Susan E. Bates	39
7	Mithramycin Represses Basal and Cigarette Smoke–Induced Expression of ABCG2 and Inhibits Stem Cell Signaling in Lung and Esophageal Cancer Cells 2012 ·Cancer Research ·Mary Zhang, Aarti Mathur, Yuwei Zhang, Sichuan Xi, Scott M. Atay, Julie A. Hong, (unknown), Trevor Upham, Clinton D. Kemp, R. Taylor Ripley, Gordon Wiegand, (unknown), Patricia Fetsch, Haresh Mani, Daniel Zlott, Robert W. Robey, Susan E. Bates, Xinmin Li, Mahadev Rao, David S. Schrump	82
8	Analyzing the Pivotal Trial That Compared Sunitinib and IFN-α in Renal Cell Carcinoma, Using a Method That Assesses Tumor Regression and Growth 2012 ·Clinical Cancer Research ·Wilfred D. Stein, Julia Wilkerson, Sindy T. Kim, Xin Huang, Robert J. Motzer, Antonio Tito Fojo, Susan E. Bates	55
9	Histone Deacetylase Inhibitors Influence Chemotherapy Transport by Modulating Expression and Trafficking of a Common Polymorphic Variant of the ABCG2 Efflux Transporter 2012 ·Cancer Research ·Agnès Basseville, Akina Tamaki, Caterina Ieranò, Shana Y. Trostel, Yvona Ward, Robert W. Robey, Ramanujan S. Hegde, Susan E. Bates	32
10	Upregulation of ABCG2 by Romidepsin via the Aryl Hydrocarbon Receptor Pathway 2011 ·Molecular Cancer Research ·Kenneth K.W. To, Robert W. Robey, Zhirong Zhan, (unknown), Susan E. Bates	43
11	EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1 , CLU , RUNX3 , and NGFR 2011 ·Cancer Research ·Chunxi Wang, Zhihui Liu, (unknown), Zhijie Li, Lifeng Wang, Jun S. Wei, Víctor E. Márquez, Susan E. Bates, Qihuang Jin, Javed Khan, Kai Ge, Carol J. Thiele	140
12	Impact of ABCB1 Allelic Variants on QTc Interval Prolongation 2010 ·Clinical Cancer Research ·Tristan M. Sissung, Erin R. Gardner, Richard Piekarz, Reuben Howden, Xiaohong Chen, Sukyung Woo, Ryan M. Franke, James Clark, Laura Miller‐DeGraff, Seth M. Steinberg, David Venzon, David J. Liewehr, Steven R. Kleeberger, Susan E. Bates, Douglas K. Price, Douglas R. Rosing, Christopher H. Cabell, Alex Sparreboom, William D. Figg	24
13	A Pharmacodynamic Study of Docetaxel in Combination with the P-glycoprotein Antagonist Tariquidar (XR9576) in Patients with Lung, Ovarian, and Cervical Cancer 2010 ·Clinical Cancer Research ·Ronan J. Kelly, Deborah Draper, Clara C. Chen, Robert W. Robey, William D. Figg, Richard Piekarz, Xiaohong Chen, Erin R. Gardner, Frank M. Balis, Aradhana M. Venkatesan, Seth M. Steinberg, Tito Fojo, Susan E. Bates	151
14	Tumor Regression and Growth Rates Determined in Five Intramural NCI Prostate Cancer Trials: The Growth Rate Constant as an Indicator of Therapeutic Efficacy 2010 ·Clinical Cancer Research ·Wilfred D. Stein, James L. Gulley, Jeff Schlom, Ravi A. Madan, William L. Dahut, William D. Figg, Yang‐Min Ning, (unknown), (unknown), Susan E. Bates, Tito Fojo	201
15	A Phase I Study of the P-Glycoprotein Antagonist Tariquidar in Combination with Vinorelbine 2009 ·Clinical Cancer Research ·Jame Abraham, Maureen Edgerly, Richard H. Wilson, Clara Chen, Ann Rutt, Susan Bakke, Robert W. Robey, (unknown), Barry R. Goldspiel, Frank M. Balis, Olaf van Tellingen, Susan E. Bates, Tito Fojo	93
16	Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant Cells 2008 ·Molecular Cancer Research ·Kenneth K.W. To, Orsolya Polgár, Lyn M. Huff, Kuniaki Morisaki, Susan E. Bates	102
17	Regulation of ABCG2 Expression at the 3′ Untranslated Region of Its mRNA through Modulation of Transcript Stability and Protein Translation by a Putative MicroRNA in the S1 Colon Cancer Cell Line 2008 ·Molecular and Cellular Biology ·Kenneth K.W. To, Zhirong Zhan, Thomas Litman, Susan E. Bates	137
18	Evidence for Microtubule Target Engagement in Tumors of Patients Receiving Ixabepilone 2007 ·Clinical Cancer Research ·Sen Hong Zhuang, (unknown), (unknown), Robert W. Robey, Dan L. Sackett, W. Marston Linehan, Susan E. Bates, Tito Fojo, Marianne S. Poruchynsky	23
19	Vascular Targeting and Antiangiogenesis Agents Induce Drug Resistance Effector GRP78 within the Tumor Microenvironment 2005 ·Cancer Research ·Dezheng Dong, (unknown), Peter Baumeister, (unknown), Fritz Costa, Frank Markland, Caryn Stiles, John B. Patterson, Susan E. Bates, Amy S. Lee	127
20	A Serial Analysis of Gene Expression (SAGE) Database Analysis of Chemosensitivity 2004 ·Cancer Research ·Wilfred D. Stein, Thomas Litman, Tito Fojo, Susan E. Bates	101

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact